What is the preferred regional block technique for thyroidectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bilateral Superficial Cervical Plexus Block (BSCPB) for Thyroidectomy

For conventional thyroidectomy, bilateral superficial cervical plexus block (BSCPB) is the preferred regional technique, using 20 mL of 0.25-0.5% bupivacaine or ropivacaine per side, administered preoperatively under ultrasound guidance. For robot-assisted transaxillary approaches, consider upgrading to intermediate cervical plexus block (ICPB) for superior analgesia.

Evidence-Based Recommendation

The 2026 ASA guideline 1 does not specifically address thyroid surgery regional blocks, focusing instead on cardiothoracic, abdominal, and mastectomy procedures. Therefore, this recommendation relies on high-quality research evidence.

Standard Thyroidectomy Approach

BSCPB provides robust postoperative analgesia with clinically meaningful benefits:

  • Significantly reduces 24-hour opioid consumption (P < 0.001) 2
  • Lowers VAS pain scores at 0,4,12, and 24 hours postoperatively 2
  • Reduces postoperative nausea and vomiting (P = 0.02) 2
  • Prolongs duration of analgesia and decreases rescue analgesic requirements 2

The 2023 meta-analysis of 31 studies with 2,273 patients 2 represents the strongest evidence base, updating previous work and confirming consistent benefits across multiple outcomes relevant to patient morbidity and quality of life.

Technical Specifications

Block parameters from high-quality trials:

  • Volume: 20 mL per side bilaterally 3, 4
  • Concentration: 0.25-0.487% bupivacaine or ropivacaine 3, 4
  • Timing: Preoperative administration before induction 4
  • Adjuvants: Adding clonidine 5 μg/mL further reduces intraoperative sufentanil requirements (0.32 vs 0.62 μg/kg, P < 0.0001) 4

When to Upgrade to Intermediate CPB

For robot-assisted transaxillary thyroidectomy or patients requiring superior analgesia, intermediate cervical plexus block outperforms superficial block:

  • Lower VAS scores at 2,4,6,12,18, and 24 hours (P < 0.05) 3
  • Prolonged analgesia duration: 10.06 vs 7.94 hours to first rescue analgesic (P = 0.017) 3
  • Reduced total analgesic consumption: 71.25 vs 101.25 μg (P = 0.011) 3
  • Effective for retroauricular robotic approaches with excellent perioperative analgesia 5

The 2026 meta-analysis 6 confirms that regional blocks for robot-assisted transaxillary thyroidectomy reduce VAS scores at 4h (WMD = -1.44), 24h (WMD = -1.28), and 48h (WMD = -0.47), all statistically significant.

Clinical Algorithm

Choose your block based on surgical approach:

  1. Conventional open thyroidectomy → Bilateral superficial CPB
  2. Robot-assisted transaxillary/retroauricular → Bilateral intermediate CPB (anterior route)
  3. High-risk patients unable to tolerate general anesthesia → Bilateral intermediate CPB as primary anesthetic 7

Important Caveats

Safety considerations:

  • BSCPB has an excellent safety profile with no major complications reported in the meta-analysis 2
  • Transient Horner's syndrome and shoulder numbness can occur but resolve spontaneously 8
  • Avoid bilateral phrenic nerve involvement when performing intermediate blocks—use ultrasound guidance to stay anterior to prevent respiratory complications 7

Multimodal integration:

  • Combine with 4g acetaminophen over 24 hours 4
  • BSCPB reduces but does not eliminate need for rescue analgesia—have nefopam or other non-opioid alternatives available 4
  • The block adds approximately 2.67 minutes to operative time 6—clinically negligible

Does not interfere with recurrent laryngeal nerve monitoring when properly performed 5, making it safe for routine use without compromising surgical safety monitoring.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.